Question: Why did Snorx, Inc. change its name to Zelegent, Inc.? Answer: The ‘Z’ is evocative of sleep. Zelegent rhymes with intelligent and sounds somewhat like elegant, which fits our mission to create the most elegant, simple-to-use, effective and desirable snoring-corrective surgical tool. Also, the name contains ENT, like successful ENT companies Acclarent, Entellus, ENTrigue, and Intersect ENT.
Question: When will the Zelegent device be available? Answer: The Zelegent device is currently an investigational device only. However, the company is working on preparing its application to the FDA to market the device in the U.S., as well as its application to obtain a CE Mark to allow it to market its device in Europe.
Question: Why would a sleep specialist otolaryngologist (an ENT doctor) want to use the Zelegent device to treat a patient suffering from snoring, instead of any of the dozens of currently-available anti-snoring devices? Answer: Currently-available anti-snoring technologies suffer from limitations, such as (a) requiring the patient to wear something at night, (b) involving traumatic surgery, (c) relying on moving the base of the tongue in order to expand the airway, or (d) being ineffective. By contrast, Zelegent believes, based on pilot clinical trial data, that the Zelegent snoring-correction device, when commercially available, will avoid all of these limitations.
Question: Don’t we have enough anti-snoring products already? Why create another one? Answer: The founders of Zelegent believed that none of the available anti-snoring technologies provided what most patients want: A quick, easy, minimally-invasive snoring solution that can be performed in a short outpatient office visit, provides effective relief from snoring, and doesn’t require the patient to wear anything at night.
CAUTION — Investigational device. Limited by Federal (or United States) law to investigational use.